Premiere Date: Friday, March 1, 2019
This activity offers CE credit for:
- Physicians (CME)
- Pharmacists (ACPE)
- ABIM (MOC)
- Other
Credit Expiration Date: Sunday, March 1, 2020
Faculty
 | Todd J. Swick, MD Clinical Assistant Professor of Neurology University of Texas Medical School Health Sciences Center at Houston Medical Director, Houston Sleep and Neurology Associates Medical Director, The Sleep Center at North Cypress Medical Center Medical Director, Apnix Sleep Diagnostic Centers Cypress, TX |
Statement of Need
The impact of residual excessive sleepiness (ES) in patients undergoing treatment for narcolepsy and OSA is profound, which highlights treatment challenges in their management. Optimal management of residual ES involves clinicians understanding the efficacy of current and emerging treatment strategies and the importance of shared decision-making tools and strategies.
In this CME Outfitters decision-tree medical simulation, expert faculty focus on residual ES in patients with OSA and narcolepsy with patient case simulations that explore the complexity of managing residual ES and provides the latest clinical updates on current and emerging therapies, strategies to facilitate patient engagement, and shared decision-making to develop comprehensive treatment strategies for long-term, effective management.
Learning Objectives
At the end of this CE activity, participants should be able to:
- Evaluate the efficacy of current and emerging treatment strategies that minimize the incidence of persistent excessive sleepiness in patients with OSA despite being optimally managed with CPAP.
- Incorporate the use of shared decision-making tools and strategies to facilitate patient engagement in disease management.
The following learning objectives pertain only to those requesting CNE or CPE credit:
- Evaluate the efficacy of current and emerging treatment strategies that minimize the incidence of persistent excessive sleepiness in patients with OSA despite being optimally managed with CPAP.
- Describe shared decision-making tools and strategies to facilitate patient engagement in disease management.
Financial Support
Supported by an educational grant from Jazz Pharmaceutical, Inc.
Target Audience
Sleep specialists, pulmonologists, primary care physicians, physician assistants, nurse practitioners, nurses, and pharmacists who treat patients with excessive sleepiness (ES).
Credit Information
CME Credit (Physicians):
CME Outfitters, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
CME Outfitters, LLC, designates this enduring material for a maximum of .25 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
CPE Credit (Pharmacists):
CME Outfitters, LLC, is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. 0.25 contact hours (0.025 CEUs) Universal Activity Number:
Enduring: 0376-0000-18-028-H01-P
Type: Knowledge-based 
ABIM MOC Credit:
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 0.25 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
Learning Format
Enduring material
Post-tests, credit request forms, and activity evaluation must be completed online (requires free account activation), and participants can print their certificate or statement of credit immediately (75% pass rate required). this website supports all browsers except Internet Explorer for Mac. For complete technical requirements and privacy policy, visit https://www.cmeoutfitters.com/privacy-and-confidentiality-policy/
Disclosure Declaration
It is the policy of CME Outfitters, LLC, to ensure independence, balance, objectivity, and scientific rigor and integrity in all of their CME/CE activities. Faculty must disclose to the participants any relationships with commercial companies whose products or devices may be mentioned in faculty presentations, or with the commercial supporter of this CME/CE activity. CME Outfitters, LLC, have evaluated, identified, and attempted to resolve any potential conflicts of interest through a rigorous content validation procedure, use of evidence-based data/research, and a multidisciplinary peer review process. The following information is for participant information only. It is not assumed that these relationships will have a negative impact on the presentations.
Dr. Swick reports that he receives research support from Avadel Pharmaceuticals; and Jazz Pharmaceuticals Inc. He is on the speakers' bureau for Arbor Pharmaceuticals; and Jazz Pharmaceuticals Inc. He is a consultant for Avadel Pharmaceuticals.
Jeffrey Helfand, DO (peer reviewer) has no disclosures to report.
Mae Ochoa, RPh (peer reviewer) has no disclosures to report.
Kashemi D. Rorie, PhD (planning committee) has nothing to disclose.
Sharon Tordoff, CHCP (planning committee) has nothing to disclose.
Disclosures were obtained from the CME Outfitters, LLC staff: Nothing to disclose.
Questions about this activity? Call us at 877.CME.PROS(877.263.7767).
PL-058-030119-43
